Multiple SARS-CoV-2 variants are circulating globally. Several new variants emerged in the fall of 2020, most notably:
In the United Kingdom (UK), a new variant of SARS-CoV-2 (known as 20I/501Y.V1, VOC 202012/01, or B.1.1.7) emerged with an unusually large number of mutations.
In South Africa, variant known as 20H/501Y.V2 or B.1.351 emerged independently of B.1.1.7. View More
Creative Diagnostics has produced a collection of recombinant antigens to evaluate the efficacy of the antibodies and vaccination for these variants.
Our team has been keeping close attention to these new variants and is working diligently to develop a serial of Lentiviral SARS-CoV-2 Mutation Pseudovirus.
Best pairs in lateral flow: If you are developing a lateral flow-based test, we recommend starting with these two capture-detection pairs: CABT-MMB1-CABT-RMJ1, and CABT-MMB1-CABT-MMB2.
New MAbs Available
We are pleased to let you know that we now have the first anti-nucleoprotein antibody (CABT-MMT2) that can not react with the B.1.1.7 variant strain but react with other COVD-19 viral strains.
This antibody can be used for COVID-19 antigen lateral flow testing in differentiating Variant B.1.1.7 and other viral strains.
We remain focused on our mission to serve life scientists to achieve their mission, faster. We know that many scientists are still diligently pursuing their research, and we'll continue to support our customers and partners worldwide.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) appeared at the end of 2019, and the sequencing was completed in January 2020... Learn more
The 2019 Coronavirus Disease (COVID-19) caused by the new coronavirus SARS-CoV-2 is now raging around the world. Existing studies have shown that SARS-CoV-2 infects host cells through the receptor ACE2... Learn more
FOLLOW US
Creative Diagnostics · 45-1 Ramsey Road · Shirley · New York · 11967
1-631-624-4882 
1-631-938-8221 
45-1 Ramsey Road, Shirley, NY 11967, USA 
